NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.53
-0.12 (-7.27%)
Open$1.65
Previous Close$1.65
Day High$1.65
Day Low$1.51
52W High$99.75
52W Low$1.11
Volume—
Avg Volume92.9K
Market Cap51.92M
P/E Ratio—
EPS$-4.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 97.74M | 92.98M | 19.57M |
| Net Income | -72,173,849 | -61,792,678 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -71,464,632 | -64,584,665 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |